Osteogenesis imperfecta type VI in childhood and adolescence: Effects of cyclical intravenous pamidronate treatment
- 31 March 2007
- journal article
- clinical trial
- Published by Elsevier BV in Bone
- Vol. 40 (3), 638-644
- https://doi.org/10.1016/j.bone.2006.10.010
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Vertebral morphometry in children and adolescents with osteogenesis imperfecta: Effect of intravenous pamidronate treatmentBone, 2006
- Pamidronate does not adversely affect bone intrinsic material properties in children with osteogenesis imperfectaBone, 2006
- The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta Type VBone, 2006
- Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfectaArchives of Disease in Childhood, 2002
- Osteogenesis Imperfecta Type VI: A Form of Brittle Bone Disease with a Mineralization DefectJournal of Bone and Mineral Research, 2002
- Cyclic Administration of Pamidronate in Children with Severe Osteogenesis ImperfectaThe New England Journal of Medicine, 1998
- Bone resorption rates in children monitored by the urinary assay of collagen type I cross-linked peptidesBone, 1994
- Lumbar bone mineral content measured by dual energy X‐ray absorptiometry in newborns and infantsActa Paediatrica, 1992
- Classification of vertebral fracturesJournal of Bone and Mineral Research, 1991
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committeeJournal of Bone and Mineral Research, 1987